In the article titled “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac” [1], there was an error in reference where it should be replaced with the article titled “A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis” [2].
Erratum | Open Access
Erratum to “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac”
Received03 Feb 2019
Accepted06 Feb 2019
Published02 Jun 2019
References
C. Walker, “Are all oral COX-2 selective inhibitors the same? a consideration of celecoxib, etoricoxib, and diclofenac,” International Journal of Rheumatology, vol. 2018, Article ID 1302835, 12 pages, 2018.
View at: Publisher Site | Google ScholarA. K. Matsumoto, A. Melian, D. R. Mandel et al., “A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis,” Journal of Rheumatology, vol. 29, no. 8, pp. 1623–1630, 2002.
View at: Google Scholar
Copyright
Copyright © 2019 Chris Walker. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.